Medicare program; end-stage renal disease prospective payment system, quality incentive program, and durable medical equipment, prosthetics, orthotics, and supplies

Fed Regist. 2013 Dec 2;78(231):72155-253.

Abstract

This rule updates and makes revisions to the End-Stage Renal Disease (ESRD) prospective payment system (PPS) for calendar year (CY) 2014. This rule also sets forth requirements for the ESRD quality incentive program (QIP), including for payment year (PY) 2016 and beyond. In addition, this rule clarifies the grandfathering provision related to the 3-year minimum lifetime requirement (MLR) for Durable Medical Equipment (DME), and provides clarification of the definition of routinely purchased DME. This rule also implements budget-neutral fee schedules for splints and casts, and intraocular lenses (IOLs) inserted in a physician's office. Finally, this rule makes a few technical amendments and corrections to existing regulations related to payment for durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) items and services.

MeSH terms

  • Durable Medical Equipment / economics*
  • Equipment and Supplies / economics*
  • Humans
  • Kidney Failure, Chronic / economics*
  • Medicare / economics*
  • Medicare / legislation & jurisprudence
  • Orthotic Devices / economics*
  • Prospective Payment System / economics
  • Prospective Payment System / legislation & jurisprudence*
  • Prostheses and Implants / economics*
  • Quality Assurance, Health Care / legislation & jurisprudence*
  • Quality Indicators, Health Care / legislation & jurisprudence
  • United States